XENE
Xenon Pharmaceuticals Inc.Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-05 | PATOU GARY |
Director |
Sell↓
Filing footnotes — Common Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 17, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025. |
Common Shares
|
1,322 |
| 2026-06-05 | Cannon Gillian |
Director |
Sell↓
Filing footnotes — Common Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 15, 2025, solely to satisfy income tax obligations related to the vesting of RSUs granted on June 5, 2025. |
Common Shares
|
1,190 |
| 2026-06-03 | GAROFALO ELIZABETH A. |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Share Option (Right to Buy)
|
10,507 |
| 2026-06-03 | Svoronos Dawn |
Director |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Restricted Share Units
|
1,593 |
| 2026-06-03 | Cannon Gillian |
Director |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Restricted Share Units
|
1,593 |
| 2026-06-03 | GAROFALO ELIZABETH A. |
Director |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Restricted Share Units
|
1,593 |
| 2026-06-03 | PATOU GARY |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Share Option (Right to Buy)
|
10,507 |
| 2026-06-03 | Gover Justin D. |
Director |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Restricted Share Units
|
1,593 |
| 2026-06-03 | Svoronos Dawn |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Share Option (Right to Buy)
|
10,507 |
| 2026-06-03 | GANNON STEVEN |
Director |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Restricted Share Units
|
1,593 |
| 2026-06-03 | Machado Patrick |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Share Option (Right to Buy)
|
10,507 |
| 2026-06-03 | GANNON STEVEN |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Share Option (Right to Buy)
|
10,507 |
| 2026-06-03 | Machado Patrick |
Director |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Restricted Share Units
|
1,593 |
| 2026-06-03 | PATOU GARY |
Director |
Award↑
Filing footnotes — Restricted Share Units (Direct)
Each RSU represents a contingent right to receive one Common Share vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Restricted Share Units
|
1,593 |
| 2026-06-03 | Gover Justin D. |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Share Option (Right to Buy)
|
10,507 |
| 2026-06-03 | Cannon Gillian |
Director |
Award↑
Filing footnotes — Share Option (Right to Buy) (Direct)
Vesting 100% on the earlier of (i) June 1, 2027 or (ii) the day before the date of the issuer's 2027 annual meeting of shareholders. |
Share Option (Right to Buy)
|
10,507 |
| 2026-06-01 | GAROFALO ELIZABETH A. |
Director |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Restricted Share Units
|
2,645 |
| 2026-06-01 | GANNON STEVEN |
Director |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the number of Common Shares withheld by the issuer to satisfy income tax withholding and remittance obligations in connection with the net settlement of the RSUs, and does not represent a sale. Represents the closing price of Common Shares on June 1, 2026 for purposes of net settlement calculations. |
Common Shares
|
1,416 |
| 2026-06-01 | GAROFALO ELIZABETH A. |
Director |
Convert↑
Filing footnotes — Common Shares (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Common Shares
|
2,645 |
| 2026-06-01 | Machado Patrick |
Director |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Restricted Share Units
|
2,645 |
| 2026-06-01 | Cannon Gillian |
Director |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Restricted Share Units
|
2,645 |
| 2026-06-01 | GANNON STEVEN |
Director |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Restricted Share Units
|
2,645 |
| 2026-06-01 | GANNON STEVEN |
Director |
Convert↑
Filing footnotes — Common Shares (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Common Shares
|
2,645 |
| 2026-06-01 | Machado Patrick |
Director |
Convert↑
Filing footnotes — Common Shares (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Common Shares
|
2,645 |
| 2026-06-01 | Gover Justin D. |
Director |
Convert↑
Filing footnotes — Common Shares (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Common Shares
|
2,645 |
| 2026-06-01 | Svoronos Dawn |
Director |
Tax↓
Filing footnotes — Common Shares (Direct)
Represents the number of Common Shares withheld by the issuer to satisfy income tax withholding and remittance obligations in connection with the net settlement of the RSUs, and does not represent a sale. Represents the closing price of Common Shares on June 1, 2026 for purposes of net settlement calculations. |
Common Shares
|
1,416 |
| 2026-06-01 | PATOU GARY |
Director |
Convert↑
Filing footnotes — Common Shares (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Common Shares
|
2,645 |
| 2026-06-01 | Gover Justin D. |
Director |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Restricted Share Units
|
2,645 |
| 2026-06-01 | PATOU GARY |
Director |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Restricted Share Units
|
2,645 |
| 2026-06-01 | Cannon Gillian |
Director |
Convert↑
Filing footnotes — Common Shares (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Common Shares
|
2,645 |
| 2026-06-01 | Svoronos Dawn |
Director |
Convert↑
Filing footnotes — Common Shares (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Common Shares
|
2,645 |
| 2026-06-01 | Svoronos Dawn |
Director |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Represents Common Shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on June 5, 2025. The RSU award vested 100% on June 1, 2026, the day before the date of the issuer's 2026 annual meeting of shareholders. |
Restricted Share Units
|
2,645 |
| 2026-05-12 | GANNON STEVEN |
Director |
Convert↑
|
Common Shares
|
3,500 |
| 2026-05-12 | GANNON STEVEN |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option are fully vested and exercisable. |
Stock Option (Right to Buy)
|
3,500 |
| 2026-03-13 | MORTIMER IAN |
Director, PRESIDENT & CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of RSUs granted on March 12, 2025. |
Common Shares
|
7,308 |
| 2026-03-13 | DiFabio Andrea |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of RSUs granted on March 12, 2025. |
Common Shares
|
1,342 |
| 2026-03-13 | KENNEY CHRISTOPHER JOHN |
Chief Medical Officer |
Sell↓
Filing footnotes — Common Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of RSUs granted on March 12, 2025. |
Common Shares
|
1,410 |
| 2026-03-12 | DiFabio Andrea |
Chief Legal Officer |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. |
Restricted Share Units
|
3,750 |
| 2026-03-12 | MORTIMER IAN |
Director, PRESIDENT & CEO |
Convert↑
Filing footnotes — Common Shares (Direct)
Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. |
Common Shares
|
12,500 |
| 2026-03-12 | KENNEY CHRISTOPHER JOHN |
Chief Medical Officer |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. |
Restricted Share Units
|
3,750 |
| 2026-03-12 | MORTIMER IAN |
Director, PRESIDENT & CEO |
Convert↓
Filing footnotes — Restricted Share Units (Direct)
Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. |
Restricted Share Units
|
12,500 |
| 2026-03-12 | KENNEY CHRISTOPHER JOHN |
Chief Medical Officer |
Convert↑
Filing footnotes — Common Shares (Direct)
Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. |
Common Shares
|
3,750 |
| 2026-03-12 | DiFabio Andrea |
Chief Legal Officer |
Convert↑
Filing footnotes — Common Shares (Direct)
Represents shares earned and vested under a restricted share unit ("RSU") award granted to the reporting person on March 12, 2025. The RSU award vests 25% on each of the first four anniversaries of the date of grant, beginning on March 12, 2026. |
Common Shares
|
3,750 |
| 2026-03-10 | DiFabio Andrea |
Chief Legal Officer |
Sell↓
Filing footnotes — Common Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of PSUs granted on March 11, 2024. |
Common Shares
|
2,607 |
| 2026-03-10 | MORTIMER IAN |
Director, PRESIDENT & CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of PSUs granted on March 11, 2024. |
Common Shares
|
11,269 |
| 2026-03-10 | KENNEY CHRISTOPHER JOHN |
Chief Medical Officer |
Sell↓
Filing footnotes — Common Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading arrangement, in the form of a durable sell-to-cover instruction, adopted by the reporting person on December 3, 2025, solely to satisfy tax withholding obligations related to the vesting of PSUs granted on March 11, 2024. |
Common Shares
|
2,771 |
| 2026-03-09 | MORTIMER IAN |
Director, PRESIDENT & CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $60.16 to $61.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Shares
|
21,515 |
| 2026-03-09 | MORTIMER IAN |
Director, PRESIDENT & CEO |
Sell↓
Filing footnotes — Common Shares (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, or shares sold. These shares were sold in multiple transactions at prices ranging from $58.16 to $59.1425, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. |
Common Shares
|
21,791 |
| 2026-03-09 | MORTIMER IAN |
Director, PRESIDENT & CEO |
Convert↓
Filing footnotes — Performance Share Units (Direct)
Represents shares earned and vested under a performance share unit ("PSU") award granted to the reporting person on March 11, 2024. The number of shares earned is based on a determination by the issuer's Board of Directors of the achievement of one or more prescribed milestones under the terms of the PSU award agreement. The PSUs vested immediately upon such determination. |
Performance Share Units
|
20,000 |
| 2026-03-09 | MORTIMER IAN |
Director, PRESIDENT & CEO |
Convert↑
|
Common Shares
|
25,000 |